DRTS ALPHA TAU MEDICAL LTD

$DRTS Packed catalyst calendar heading into the end of the year. Between ReSTART, ReGAIN, and IMPACT, $DRTS is being validated across multiple solid tumor indications. If these readouts land, that $30 target from Barclays feels conservative. Where do you see the ceiling if all three deliver?

$DRTS Back to breaking records. New ATH at $15.20 and highest close at $15.04. looking for momentum to continue Thursday.

$DRTS Yesterday started with an ugly morning followed by a near full recovery that was nice to see, looking to see if thar strength continues today, definitely worth paying attention to.

$DRTS Mark this post. With FDA approval and next round of results, $50 is very feasible. Once commercialization begins, we could hit $100 and still be fairly valued based on TAM. Either we scale ourselves or get bought out. Regardless, $10bil market cap over the next years is still conservative with execution. That would be $84.75 per share fully diluted. I see this as an assymetric play: -Early results have been unprecedented. -Unicorn company with a patented first-of-kind technology. -Tolmar deal is validation that even with limited studies, commercial potential outweighs risks. -Manufacturing scaling pre-approval

$DRTS management is in new york today taking 1x1 meetings at the barclays biotech day. funds sit down with the team face to face. this is how institutional interest gets built, quietly, one meeting at a time.

$DRTS Getting beat up with the poor macro and interest rates going up as biotechs do. I still believe this is a groundbreaking therapy and longterm should see multiples from here.

$DRTS feels like the last chance to load up before $15 and beyond hits hard and $14 is forever in the rear view mirror. Alpha Tau meeting with massive financial institutions in October. Hang on!

$DRTS If you look at previous biotech runs with similar pipeline milestones, the big move always starts months before the actual final approval. $DRTS is about to enter that sweet spot where anticipation drives the next massive leg up.

​A minor pullback this week doesn't change the thesis. Core fundamentals for $DRTS remain untouched, and the upcoming catalysts are just one week closer.

$DRTS New week, I’m waiting for the price break out, technically it look like it’s time. I hope this happens even before a major announcement from the company

$DRTS When fundamentals and technicals align like this, I’m very happy to be a shareholder.

$DRTS Fundamentals look great, and technically the chart is strong across the primary, secondary, and short term trends. This looks like a healthy consolidation after a new high, not weakness. And definitely headed to a new high. 

I follow $DRTS on Reddit. Today was hilarious as people were tasked with “making a bear case.” When people are struggling to concoct a bear case for a company that’s up 300%+ over the past year, you’ve got an absolute gem.

$DRTS Back to $15 on a down day in the market, we definitely are going to break out above $16 in the near future

$DRTS after closing Monday at a all time high close, the stock took a technical breather yesterday allowing people a chance to buy a little cheaper

$DRTS 30k shares moved this 1.5% up. Absolutely nobody is selling. When this gets picked up by the hype traders it could go ballistic.

$DRTS With Biotech’s data driven and oftentimes has binary price movement, it presents a great hedge against tech and the general macro trend. Unfortunately cancer isn’t going anywhere any time soon, and with DRTS global, dynamic solution, it’s well insulated from the political drama and macro climate more than a lot of companies. Get your hedge in today!

$DRTS This company never sleeps-they’ve posted hiring over last 3 days for 5 positions:

$DRTS The stock is one catalyst away from going to the moon. Let’s get that next catalyst and go into space!

$DRTS im used to being in tickers with dirtbag forums. It's awfully quiet in here for how well the stock is doing